Molecule Holdings Inc.
EVRRFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$626130
P/E Ratio—
52W High$0.0025
52W Low$0.0025
Molecule Holdings Inc.（EVRRF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · EVRRF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2022-10 | 2021-10 | 2020-10 | 2019-10 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $1.97M | $0.46M | $0.00M | $0.00M |
| Cost of Revenue | $3.04M | $0.95M | $0.05M | $0.03M |
| Gross Profit | ($1.07M) | ($0.50M) | ($0.05M) | ($0.03M) |
| Gross Margin %(computed) | -54.56% | -109.77% | — | — |
| Operating Expenses | ||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $2.59M | $2.43M | $1.88M | $1.07M |
| Total Operating Expenses | $2.84M | $2.89M | $1.83M | $1.10M |
| Operating Income | ($3.91M) | ($3.19M) | ($1.88M) | ($1.08M) |
| Operating Margin %(computed) | -198.86% | -701.11% | — | — |
| Interest Income | $0.00M | $0.00M | $0.01M | $0.02M |
| Interest Expense | $0.63M | $0.66M | $0.04M | $0.02M |
| Income Before Tax | ($4.54M) | ($4.23M) | ($3.33M) | ($1.09M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.02M |
| Net Income | ($4.54M) | ($4.23M) | ($3.33M) | ($1.09M) |
| Net Margin %(computed) | -230.84% | -928.56% | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-0.05 | $-0.05 | $-0.03 | $-0.24 |
| Wtd Avg Shares | 97.11M | 91.86M | 75.71M | 4.66M |
| EBITDA | ($3.26M) | ($2.87M) | ($3.23M) | ($1.05M) |
| EBITDA Margin %(computed) | -165.47% | -631.46% | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · CAD · M
深入了解Molecule Holdings Inc.
关于Molecule Holdings Inc.（EVRRF）损益表
Molecule Holdings Inc.（EVRRF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年，EVRRF实现营收$0.00B，毛利润($0.00B)（毛利率-54.56%），净利润($0.00B)（净利率-230.84%）。
常见问题
EVRRF · 4 问Molecule Holdings Inc.（EVRRF）2022财年营收为$0.00B，同比up332.4%。
EVRRF revenueEVRRF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09